# Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

> **NCT06142656** · PHASE2,PHASE3 · RECRUITING · sponsor: **October 6 University** · enrollment: 60 (estimated)

## Conditions studied

- Poly Cystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin Hydrochloride tablet
- **DRUG:** Vildagliptin 50 MG

## Key facts

- **NCT ID:** NCT06142656
- **Lead sponsor:** October 6 University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-25
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06142656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06142656, "Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06142656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*